Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	111.8	102.32	135.82	135.03	52.07	61.03
Short-Term Investments	229.11	272.33	252.44	331.83	380.74	306.71
Cash & Short-Term Investments	340.91	374.64	388.26	466.86	432.81	367.74
Cash Growth	-13.51%	-3.51%	-16.84%	7.87%	17.70%	17.82%
Receivables	44.6	47.1	34.16	33.51	32.47	30.04
Inventory	1.92	1.73	1.36	1.19	1.03	1.28
Prepaid Expenses	20.48	15.42	9.17	6.23	12	10.03
Restricted Cash	-	-	-	-	-	0.06
Other Current Assets	-	-	-	11.5	-	-
Total Current Assets	407.91	438.89	432.95	519.29	478.3	409.15
Property, Plant & Equipment	12.48	12.68	9.14	10.97	12.39	14.6
Other Intangible Assets	112.34	114.1	121.37	18.57	20.08	21.56
Long-Term Deferred Tax Assets	89.15	81.44	75	74.04	74.88	81.52
Other Long-Term Assets	10.06	9.1	9.99	11.38	8.15	6.64
Total Assets	631.94	656.2	648.44	634.25	593.79	533.46
Accounts Payable	5.99	3.5	7.15	12.69	0.93	1.05
Accrued Expenses	34.9	31.32	28.92	30.53	31.2	27.99
Current Portion of Leases	4.39	4.27	2.4	2.33	2.31	2.12
Other Current Liabilities	58.64	60.9	49.24	45.89	39.98	34.78
Total Current Liabilities	103.92	99.98	87.7	91.44	74.42	65.94
Long-Term Leases	7.35	8.09	7.01	8.81	10.06	11.5
Other Long-Term Liabilities	9.25	9.59	8.83	6.8	4.39	2.76
Total Liabilities	120.52	117.66	103.53	107.05	88.86	80.19
Common Stock	0.06	0.06	0.06	0.06	0.06	0.06
Additional Paid-In Capital	714.76	712.71	700.27	686.24	669.22	650.3
Retained Earnings	-203.79	-174.29	-155.39	-157.9	-164.18	-197.33
Comprehensive Income & Other	0.38	0.07	-0.03	-1.19	-0.18	0.24
Shareholders' Equity	511.42	538.55	544.91	527.2	504.93	453.27
Total Liabilities & Equity	631.94	656.2	648.44	634.25	593.79	533.46
Total Debt	11.75	12.36	9.4	11.14	12.37	13.61
Net Cash (Debt)	329.16	362.28	378.86	455.72	420.45	354.13
Net Cash Growth	-14.55%	-4.38%	-16.86%	8.39%	18.73%	19.02%
Net Cash Per Share	5.64	6.23	6.58	8.00	7.39	6.42
Filing Date Shares Outstanding	58.93	58.32	57.54	56.79	55.91	54.88
Total Common Shares Outstanding	58.93	58.31	57.53	56.78	55.9	54.87
Working Capital	303.99	338.91	345.25	427.86	403.88	343.21
Book Value Per Share	8.68	9.24	9.47	9.28	9.03	8.26
Tangible Book Value	399.07	424.45	423.54	508.63	484.85	431.71
Tangible Book Value Per Share	6.77	7.28	7.36	8.96	8.67	7.87
Machinery	-	8.23	7.78	7.58	7.03	6.71
Leasehold Improvements	-	5.47	5.44	5.42	5.46	5.46

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q